Optimal methods to characterize the G93A mouse model of ALS
Authors:
- Francisco J. Miana‐MenaFMFrancisco J. Miana‐Mena
- Maria J. MuñozMMMaria J. Muñoz
- Gema YagüeGYGema Yagüe
- Mario MendezMMMario Mendez
- Maria MorenoMMMaria Moreno
- Jesús CirizaJCJesús Ciriza
- Pilar ZaragozaPZPilar Zaragoza
- Rosario OstaRORosario Osta
- 1 March 2005
- journal article
- research article
- Published by Taylor & Francis in Amyotrophic Lateral Sclerosis
- Vol. 6 (1) , 55-62
Abstract
In the present study, we used the SOD1 (G93A) mutant transgenic mice as a model of amyotrophic lateral sclerosis (ALS). This model is widely used as a laboratory tool to study experimental treatments in vivo for ALS to investigate new therapeutic strategies for this neurodegenerative disease. Such studies require the objective quantification of different parameters while mice develop the disease. We have applied a battery of different and specific tests: scoring of motor deficits by a trained observer, weighing, survival measure, hanging wire test, rotarod task and electromyography, most of them commonly used to evaluate G93A animals. We have critically compared these methods, showing the significant influence of gender on the onset of symptoms, and the optimal moment to apply each test. These results should be taken into account in future therapeutic assays on this ALS model.Keywords
This publication has 11 references indexed in Scilit:
- Sexual differences in onset of disease and response to exercise in a transgenic model of ALSNeuromuscular Disorders, 2003
- Assessing disease onset and progression in the SOD1 mouse model of ALSNeuroReport, 2003
- Behavioral phenotyping of mice in pharmacological and toxicological researchExperimental and Toxicologic Pathology, 2003
- Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALSAnnals of Neurology, 2002
- Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutationNeuropathology, 2001
- Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests1Published on the World Wide Web on 2 December 1998.1Brain Research, 1999
- A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase ( SOD1 ) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosisActa Neuropathologica, 1997
- SUPEROXIDE RADICAL AND SUPEROXIDE DISMUTASESAnnual Review of Biochemistry, 1995
- Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase MutationScience, 1994
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993